Cargando…
P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431178/ http://dx.doi.org/10.1097/01.HS9.0000971260.77309.53 |
| _version_ | 1785091139851780096 |
|---|---|
| author | Malafronte, Rosalia Bellesi, Silvia Maiolo, Elena Iacovelli, Camilla Campana, Fabrizia Fatone, Federica Bellisario, Flaminia Alma, Eleonora Alò, Francesco D’ Hohaus, Stefan |
| author_facet | Malafronte, Rosalia Bellesi, Silvia Maiolo, Elena Iacovelli, Camilla Campana, Fabrizia Fatone, Federica Bellisario, Flaminia Alma, Eleonora Alò, Francesco D’ Hohaus, Stefan |
| author_sort | Malafronte, Rosalia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311782023-08-17 P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA Malafronte, Rosalia Bellesi, Silvia Maiolo, Elena Iacovelli, Camilla Campana, Fabrizia Fatone, Federica Bellisario, Flaminia Alma, Eleonora Alò, Francesco D’ Hohaus, Stefan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431178/ http://dx.doi.org/10.1097/01.HS9.0000971260.77309.53 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Malafronte, Rosalia Bellesi, Silvia Maiolo, Elena Iacovelli, Camilla Campana, Fabrizia Fatone, Federica Bellisario, Flaminia Alma, Eleonora Alò, Francesco D’ Hohaus, Stefan P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA |
| title | P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA |
| title_full | P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA |
| title_fullStr | P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA |
| title_full_unstemmed | P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA |
| title_short | P1091: CLINICAL IMPLICATIONS OF T CELL SUBSET COMPOSITION DURING MAINTENANCE THERAPY AFTER FIRST-LINE IMMUNOCHEMOTHERAPY CONTAINING BENDAMUSTINE IN PATIENTS WITH FOLLICULAR LYMPHOMA |
| title_sort | p1091: clinical implications of t cell subset composition during maintenance therapy after first-line immunochemotherapy containing bendamustine in patients with follicular lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431178/ http://dx.doi.org/10.1097/01.HS9.0000971260.77309.53 |
| work_keys_str_mv | AT malafronterosalia p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT bellesisilvia p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT maioloelena p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT iacovellicamilla p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT campanafabrizia p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT fatonefederica p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT bellisarioflaminia p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT almaeleonora p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT alofrancescod p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma AT hohausstefan p1091clinicalimplicationsoftcellsubsetcompositionduringmaintenancetherapyafterfirstlineimmunochemotherapycontainingbendamustineinpatientswithfollicularlymphoma |